Planet Labs Stock Has Quickly Fallen 40%. Time to Buy the Dip?

Planet Labs shares have fallen more than 40% in the past month, from about $51 in May to roughly $28, driven largely by capital rotation into SpaceX at its IPO. Q1 fiscal 2027 revenue rose 42% year over year to $94.2 million and backlog increased 72% to $906 million, but the company still posted a $138.9 million net loss, including a $106.5 million noncash warrant-liability adjustment. Cash and short-term investments totaled $730.8 million, and defense-related revenue grew over 65%, but the stock remains expensive at 26.9x sales and profitability is still years away.

Analysis

The market is treating this as a multiple-compression event, not a fundamental break. That matters because Planet’s rerating was driven by scarcity value in the private/public space-data complex; if capital is now being pulled toward a new private-market liquidity story, every listed name with “optionality” gets de-rated first, regardless of backlog quality. In that regime, even good quarters can fail to stabilize the stock until the flow bid from generalist growth buyers returns.

The key second-order effect is competitive positioning in defense-adjacent geospatial data. The fastest-growing demand pool is sovereign and intelligence use cases, where procurement cycles are long but once embedded the switching costs rise quickly; that makes contract wins more valuable than near-term margin optics. The risk is that Planet’s revenue mix shifts toward lower-margin mission-critical work before operating leverage arrives, prolonging the path to GAAP profitability even if top-line growth stays strong.

The balance sheet gives management time, but it also creates a paradox: ample liquidity reduces dilution risk, yet it can encourage investors to underwrite a slower transition to earnings because the company doesn’t need to “prove it now.” That’s why the stock can remain volatile for months even if fundamentals continue to improve. The contrarian view is that the recent drawdown may already discount a lot of bad news; if sentiment normalizes and the company keeps posting 30%+ growth with backlog expansion, the next rerating could be abrupt rather than gradual.

Key Decisions for Investors

• Trade idea: Buy PL on further post-rally weakness only, not strength; prefer scaling in over 2-4 weeks. Risk/reward is better if the stock re-tests the low-$20s, where downside from cash-rich support is more limited and upside back toward prior highs can be driven by sentiment normalization.
• Pair trade: Long PL / short BKSY for 1-3 months. PL has a better balance sheet and more backlog visibility; BKSY screens cheaper but is more exposed to execution/margin disappointment, making it a cleaner relative-value hedge against sector de-rating.
• Options: Sell downside puts in PL only after volatility remains elevated for another 1-2 weeks, using strikes below recent support. The thesis is that implied vol should stay bid while flow pressure persists, but the cash position reduces bankruptcy-style tail risk.
• Avoid adding to longs ahead of the next print; wait for evidence that defense-intelligence growth is translating into operating leverage. If gross margin or opex discipline stalls, the market will re-open the profitability debate and extend the multiple compression.
• For high-conviction traders: consider a tactical short only if PL breaks technical support on volume, with a tight stop above the prior 20-day moving average. This is a flow-driven short, not a structural one, so the risk/reward deteriorates quickly once the forced selling completes.